Pietro Scalfaro

Title: Pietro Scalfaro: Innovator in Hepatitis C Treatment

Introduction

Pietro Scalfaro is a notable inventor based in Lausanne, Vaud, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hepatitis C infection. With a total of 2 patents, Scalfaro's work focuses on innovative uses of cyclosporins.

Latest Patents

Scalfaro's latest patents include the following:

1. **Use of a cyclosporin for the treatment of hepatitis C infection and pharmaceutical composition comprising said cyclosporin** - This invention relates to the use in the treatment of HCV infection, either as single active agents or in combination with another active agent, of a cyclosporin having increased cyclophilin binding activity and essentially lacking immunosuppressive activity.

2. **Use of selected cyclosporins for the treatment of hepatitis C infection** - This invention also pertains to the treatment of HCV infection, utilizing cyclosporins with enhanced cyclophilin binding activity while being devoid of immunosuppressive effects.

Career Highlights

Throughout his career, Pietro Scalfaro has focused on advancing medical treatments through innovative pharmaceutical compositions. His research has contributed to a better understanding of how cyclosporins can be utilized effectively in treating hepatitis C.

Collaborations

Scalfaro has worked alongside Jean-Maurice Dumont, contributing to the development of his patents and enhancing the research efforts in the field of hepatitis C treatment.

Conclusion

Pietro Scalfaro's contributions to the pharmaceutical industry, particularly in the treatment of hepatitis C, highlight his innovative spirit and dedication to improving patient outcomes. His patents reflect a commitment to advancing medical science through effective treatments.